Telehealth ad compliance checker for Meta and Google

The checker runs a set of rules taken from Meta's and Google's health ad policies and the FTC's guidance on health claims and endorsements. Each rule has a summary, a link to its primary source and the date we last checked that source.

• Pass 1 runs in your browser. Telehealth Media heuristics look for wording that often draws a closer review: naming a prescription drug, implying the reader has a condition, promising a result in a set time, absolute promises such as guarantees, and compounded-drug equivalence claims.
• Each match is shown with the words that triggered it, the rule, a plain reason and the source link.
• The overall result is low, medium or high risk of review. The checker never says an ad is approved or compliant, because only the platform decides that.
• The claims ladder sorts each line from a plain service description up to absolute or equivalence claims, so you can see which lines carry the risk.

Separate several ads with a line containing only three dashes to check up to 50 at once.

Copy: "Same as Ozempic, FDA-approved, lose 30 lbs" for a GLP-1 brand on Meta.

Overall: high risk of review. A lower-risk version talks about the service: "Talk to a licensed provider online about weight care options."

• Most telehealth rejections come from a few patterns: naming the drug without authorization, "you" language about a condition, and specific results.
• Ads that promote the telehealth service in general need no prescription drug authorization on Meta. Many angles work without naming the drug at all.
• Meta's Health and Wellness policy bars fat-pinching close-ups and timeframe promises without qualifiers (checked 3 Nov 2026).
• A low result means no pattern matched, not that the ad will pass. Review still depends on images, landing pages and account history.